REYON PHARMACEUTICAL CO., LTD
Develops and manufactures APIs, generics, contrast agents, and biopharmaceuticals.
102460 | KO
Overview
Corporate Details
- ISIN(s):
- KR7102460003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로 620 에이동 12층 (대치동, 미래에셋타워), 강남구
- Website:
- https://www.reyonpharm.co.kr/
- Sector:
- Manufacturing
Description
REYON PHARMACEUTICAL CO., LTD. is a research-driven company engaged in the development and manufacturing of chemical and biopharmaceutical products. Its primary business areas encompass the production of Active Pharmaceutical Ingredients (APIs), a diverse portfolio of generic medicines, and contrast agents. The company leverages advanced synthesis know-how to supply high-value APIs to domestic and international partners. A key strategic focus is the development of next-generation biopharmaceuticals, including gene therapies for conditions like wet age-related macular degeneration and NK cell therapies for solid cancers. Reyon is also expanding its capabilities to offer contract development and manufacturing (CDMO) services for complex biologic drugs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-21 00:00 |
사업보고서 (2023.12)
|
Korean | 1.6 MB | ||
| 2024-03-12 00:00 |
주주총회소집공고
|
Korean | 985.1 KB | ||
| 2024-03-12 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB | ||
| 2024-03-12 00:00 |
의결권대리행사권유참고서류
|
Korean | 954.7 KB | ||
| 2024-02-28 00:00 |
최대주주등소유주식변동신고서
|
Korean | 38.0 KB | ||
| 2024-02-28 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 131.6 KB | ||
| 2024-02-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.7 KB | ||
| 2024-02-22 00:00 |
주주총회소집결의
|
Korean | 11.8 KB | ||
| 2024-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.2 KB | ||
| 2024-02-15 00:00 |
현금ㆍ현물배당결정
|
Korean | 8.6 KB | ||
| 2023-11-28 00:00 |
[기재정정]분기보고서 (2023.09)
|
Korean | 1.5 MB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.5 MB | ||
| 2023-11-08 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 130.2 KB | ||
| 2023-11-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.6 KB | ||
| 2023-11-08 00:00 |
최대주주등소유주식변동신고서
|
Korean | 42.7 KB |
Automate Your Workflow. Get a real-time feed of all REYON PHARMACEUTICAL CO., LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for REYON PHARMACEUTICAL CO., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for REYON PHARMACEUTICAL CO., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
